Columbia-based Martek Biosciences Corp. Thursday said it agreed to the $14 million sale of a "significant portion" of a Kentucky plant used to make a health supplement for infant formula.
The sale is part of a restructuring effort to lower Martek's production costs as prices for its infant formula additive, which benefits brain development, have dropped. The deal includes a majority of the land and buildings at the site in Winchester, Ky., but does not include the sale or rights to any of Martek's patents or other technologies.
